Invest in IPO

Sequent Scientific Ltd

  • BSE Code : 512529
  • NSE Symbol : SEQUENT
  • ISIN : INE807F01027
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 161.13 5.97(3.85%)

Open Price ()

153.00

Prev. Close ()

155.16

Volume (No’s)

1,484,320

Market Cap ()

3,883.69

Low Price ()

152.54

High Price ()

162.10

 

Book Closure

From Date To Date Announcement
20-May-2025 NA Sequent Scientific Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please be informed that the Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday May 20 2025 inter alia to: a)consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2025. b)recommend dividend if any on the equity shares of the Company for the year ended March 31 2025.
19-Feb-2025 20-Feb-2025 Postal ballot Notice Newspaper publication -Notice of Postal ballot (As per BSE Announcement Dated on 21/01/2025) Postal Ballot-Scrutinizer''s Report (As Per BSE Announcement Dated on: 20/02/2025)
11-Feb-2025 NA SEQUENT SCIENTIFIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Meeting of the Board of Directors of SeQuent Scientific Limited is scheduled to be held on Tuesday February 11 2025 to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2024 Pursuant to Regulation 30 and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors at its Meeting held today i.e., February 11, 2025, upon the recommendation of the Audit Committee, has inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024 (As Per BSE Announcement Dated on: 11/02/2025)
17-Dec-2024 NA Update on change in Directorate and Key Managerial personnel
16-Dec-2024 NA Update on change in Directorate and Key Managerial personnel

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew